A nationwide settlement has been reached in several class action lawsuits relating to two drugs and some Canadians could get a chunk of the money.

The lawsuits raised various allegations against prescription drugs OxyContin and OxyNEO. They sought damages on behalf of Canadians for harm and injuries which were allegedly related to the use of the opioids.

Both OxyContin and OxyNeo deny the allegations made in the lawsuits.

Courts in Ontario, Quebec, Nova Scotia, and Saskatchewan approved the $20 million settlement as being “fair, reasonable, and in the best interest of Class Members.”

You might also like:
• Canadian university professor dies while summiting Mount Everest
• Fight or flight: Passengers take matters into their own hands after Air Canada delay
• Major airline gives staff massive 8-month salary bonus after huge annual profits

Who’s eligible for the settlement payment?

According to a news release from the law firms, the settlement applies to any Canadian (including their estates and provincial insurers) who at any time between January 1, 1996, and February 28, 2017, were prescribed and ingested OxyContin and/or OxyNEO tablets that were manufactured, marketed, and/or sold in the country.

This includes the following provinces:

Ontario Class: Class Members whose prescription occurred in Ontario and/or British Columbia

Quebec Class: Class Members whose prescription occurred in Quebec

Atlantic Canada Class: Class Members whose prescription occurred in Nova Scotia, Newfoundland and Labrador, New Brunswick, and/or Prince Edward Island

Saskatchewan Class: Class Members whose prescription occurred in Saskatchewan, Alberta, Manitoba, the Yukon, the Northwest Territories, and/or Nunavut

A $20 million Settlement Payment has been created.

It’ll be used to pay the claims of provincial health insurers, the costs of settlement notice and administration, compensation of people approved to make a claim, and legal fees.

Payments to approved claimants will be made to members of the class action lawsuit who show that they “suffered one or more of the injuries described in greater detail in the Compensation Protocol, which are all subject to various eligibility criteria and maximum payment values.”

Not all members of the class action lawsuit will be eligible for compensation, according to the law firms.

The types of injuries that may qualify for compensation include fatal and non-fatal overdose, addiction, and various life complications arising from dependency alleged to be associated with OxyContin and/or OxyNEO use.

For more information on eligibility, or if you want to claim a payment, you can review the settlement here.

To be able to receive a payment, you must file a claim before February 27, 2024.